Silicon Labs Reports Fourth Quarter and Full Year 2022 Results - Form 8-K

Silicon Labs Reports Fourth Quarter and Full Year 2022 Results

IoT leader doubles revenue in two years to more than $1 billion

AUSTIN, Texas - February 1, 2023 - Silicon Labs (NASDAQ: SLAB), a leader in secure, intelligent wireless technology for a more connected world, reported financial results for the fourth quarter, which ended December 31, 2022. Revenue exceeded the top end of the guidance range at $257 million, up 23% year-on-year. Silicon Labs saw full-year revenue growth across both its Industrial & Commercial and Home & Life product groups.

"We are incredibly proud of our team's execution in doubling our organic revenue in two years to more than $1 billion annually, while at the same time increasing our design wins by 120%," said Matt Johnson, President and Chief Executive Officer at Silicon Labs. "The strength of our opportunity funnel and design win pipeline gives us confidence in our ability to continue expanding our leadership position in IoT while navigating the current economic uncertainty."

Fourth Quarter Financial Highlights

·	Revenue was $257 million, up 23% year-on-year

·	Industrial & Commercial revenue for the quarter was $157 million, up 36% year-on-year

·	Home & Life revenue for the quarter was $100 million, up 8% year-on-year

·	Gross margin of 61% was favorable due to strong product, pricing, and customer mix in the quarter

Results on a GAAP basis:

·	GAAP gross margin was 61%

·	GAAP R&D expenses were $87 million

·	GAAP SG&A expenses were $47 million

·	GAAP operating income as a percentage of revenue was 9%

·	GAAP diluted earnings per share were $0.76

Results on a non-GAAP basis, excluding the impact of stock compensation, amortization of acquired intangible assets, and certain other items as set forth in the below GAAP to Non-GAAP reconciliation tables were as follows:

·	Non-GAAP gross margin was 61%

·	Non-GAAP R&D expenses were $70 million

·	Non-GAAP SG&A expenses were $39 million

·	Non-GAAP operating income as a percentage of revenue was 19%

·	Non-GAAP diluted earnings per share were $1.31

Business Highlights

·

The Connectivity Standards Alliance (CSA) announced the release of Matter 1.0, the application layer protocol developed specifically to address device interoperability within the smart home. Silicon Labs is the leading semiconductor company code contributor to Matter, and as of the end of 2022, claims 86% of Matter over Thread's industry certifications. Silicon Labs has become a one-stop resource for Matter devices, border routers, and bridges so developers can easily bridge Matter to other IoT development platforms like Wi-Fi, Zigbee, Thread, and Z-Wave while leveraging their experience with Silicon Labs' hardware and tools.

·	Silicon Labs President and CEO Matt Johnson was elected Chair of the Semiconductor Industry Association (SIA) Board of Directors. SIA represents 99% of the U.S. semiconductor industry by revenue and nearly two-thirds of non-U.S. chip firms.

·

Completed the buyback of $200 million of the company's shares in the quarter, resulting in the retirement of 1.6 million shares and bringing the total share repurchase activity since the announcement of the divestiture in April 2021 to more than $2 billion, retiring more than 25% of the then outstanding shares.

Business Outlook

The company expects first-quarter revenue to be between $242 to $252 million. The company also estimates the following results:

On a GAAP basis:

·	GAAP gross margin of approximately 63%

·	GAAP operating expenses of approximately $139 million

·	GAAP effective tax rate of approximately 31%

·	GAAP diluted earnings per share between $0.36 to $0.46

On a non-GAAP basis, excluding the impact of stock compensation, amortization of acquired intangible assets, and certain other items as set forth in the reconciliation tables:

·	Non-GAAP gross margin of approximately 63%

·	Non-GAAP operating expenses of approximately $111 million

·	Non-GAAP effective tax rate of approximately 23%

·	Non-GAAP diluted earnings per share between $1.07 to $1.17

Earnings Webcast and Conference Call

Silicon Labs will host an earnings conference call to discuss the quarterly results and answer questions at 7:30 am CDT today. An audio webcast will be available on Silicon Labs' website (www.silabs.com) under Investor Relations. In addition, the company will post an audio recording of the event at silabs.com/investors and make a replay available through March 1, 2023, online or by calling (877) 344-7529 (US) or (412) 317-0088 (international) and entering access code 2355666.

About Silicon Labs

Silicon Labs (NASDAQ: SLAB) is a leader in secure, intelligent wireless technology for a more connected world. Our integrated hardware and software platform, intuitive development tools, thriving ecosystem, and robust support make us an ideal long-term partner in building advanced industrial, commercial, home and life applications. We make it easy for developers to solve complex wireless challenges throughout the product lifecycle and get to market quickly with innovative solutions that transform industries, grow economies, and improve lives. silabs.com

Forward-Looking Statements

This press release contains forward-looking statements based on Silicon Labs' current expectations. The words "believe", "estimate", "expect", "intend", "anticipate", "plan", "project", "will", and similar phrases as they relate to Silicon Labs are intended to identify such forward-looking statements. These forward-looking statements reflect the current views and assumptions of Silicon Labs and are subject to various risks and uncertainties that could cause actual results to differ materially from expectations. Among the factors that could cause actual results to differ materially from those in the forward-looking statements are the following: the competitive and cyclical nature of the semiconductor industry; the challenging macroeconomic environment; geographic concentration of manufacturers, assemblers, test service providers and customers in Asia that subjects Silicon Labs' business and results of operations to risks of natural disasters, epidemics or pandemics, war and political unrest; risks that demand and the supply chain may be adversely affected by military conflict (including between Russia and Ukraine), terrorism, sanctions or other geopolitical events globally (including conflict between Taiwan and China); risks that Silicon Labs may not be able to maintain its historical growth; quarterly fluctuations in revenues and operating results; difficulties developing new products that achieve market acceptance; risks associated with international activities (including trade barriers, particularly with respect to China); intellectual property litigation risks; risks associated with acquisitions and divestitures; product liability risks; difficulties managing and/or obtaining sufficient supply from Silicon Labs' distributors, manufacturers and subcontractors; dependence on a limited number of products; absence of long-term commitments from customers; inventory-related risks; difficulties managing international activities; risks that Silicon Labs may not be able to manage strains associated with its growth; credit risks associated with its accounts receivable; dependence on key personnel; stock price volatility the impact of COVID-19 on the U.S. and global economy; debt-related risks; capital-raising risks; the timing and scope of share repurchases and/or dividends; average selling prices of products may decrease significantly and rapidly; information technology risks; cyber-attacks against Silicon Labs' products and its networks and other factors that are detailed in the SEC filings of Silicon Laboratories Inc. Silicon Labs disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. References in this press release to Silicon Labs shall mean Silicon Laboratories Inc.

Note to editors: Silicon Laboratories, Silicon Labs, the "S" symbol, and the Silicon Labs logo are trademarks of Silicon Laboratories Inc. All other product names noted herein may be trademarks of their respective holders.

CONTACT: Thomas Haws, Investor Relations Manager, (512) 416-8500, [email protected]

Silicon Laboratories Inc.

Condensed Consolidated Statements of Operations

(In thousands, except per share data)

(Unaudited)

		Three Months Ended			Year Ended
		December 31, 2022			January 1, 2022			December 31, 2022			January 1, 2022
Revenues		$	257,325			$	208,680			$	1,024,106			$	720,860
Cost of revenues			100,028				80,849				381,549				295,468
Gross profit			157,297				127,831				642,557				425,392
Operating expenses:
Research and development			86,649				71,705				332,326				273,208
Selling, general and administrative			46,573				53,487				190,971				185,022
Operating expenses			133,222				125,192				523,297				458,230
Operating income (loss)			24,075				2,639				119,260				(32,838	)
Other income (expense):
Interest income and other, net			4,299				2,595				13,915				5,696
Interest expense			(1,849	)			(6,628	)			(6,723	)			(31,033	)
Income (loss) from continuing operations before income taxes			26,525				(1,394	)			126,452				(58,175	)
Provision for income taxes			1,579				884				38,450				13,427
Equity-method earnings			415				7,791				3,400				13,728
Income (loss) from continuing operations			25,361				5,513				91,402				(57,874	)
Income (loss) from discontinued operations, net of income taxes			--				(8,611	)			--				2,175,273
Net income (loss)		$	25,361			$	(3,098	)		$	91,402			$	2,117,399
Basic earnings (loss) per share:
Continuing operations		$	0.78			$	0.14			$	2.61			$	(1.35	)
Net income		$	0.78			$	(0.08	)		$	2.61			$	49.44
Diluted earnings (loss) per share:
Continuing operations		$	0.76			$	0.13			$	2.54			$	(1.35	)
Net income		$	0.76			$	(0.08	)		$	2.54			$	47.78
Weighted-average common shares outstanding:
Basic			32,542				38,965				35,086				42,830
Diluted			33,265				41,031				36,042				44,315

Non-GAAP Financial Measurements

In addition to the GAAP results provided throughout this document, Silicon Labs has provided non-GAAP financial measurements on a basis excluding non-cash and other charges and benefits. Details of these excluded items are presented in the tables below, which reconcile the GAAP results to non-GAAP financial measurements.

The non-GAAP financial measurements do not replace the presentation of Silicon Labs' GAAP financial results. These measurements provide supplemental information to assist management and investors in analyzing Silicon Labs' financial position and results of operations. Silicon Labs has chosen to provide this information to investors to enable them to perform meaningful comparisons of past, present, and future operating results and as a means to emphasize the results of core on-going operations.

Unaudited Reconciliation of GAAP to Non-GAAP Financial Measures

(In thousands, except per share data)

		Three Months Ended December 31, 2022
Non-GAAP Income Statement Items		GAAP Measure			GAAP Percent of Revenue			Stock Compensation Expense			Intangible Asset Amortization			Termination Costs & Other			Non- GAAP Measure			Non-GAAP Percent of Revenue
Revenues		$	257,325
Gross profit			157,297				61.1	%		$	318			$	--			$	--			$	157,615				61.3	%
Research and development			86,649				33.7	%			9,378				6,724				873				69,674				27.1	%
Selling, general and administrative			46,573				18.1	%			7,601				19				(279	)			39,232				15.2	%
Operating income			24,075				9.4	%			17,297				6,743				594				48,709				18.9	%

		Three Months Ended December 31, 2022
Non-GAAP Earnings Per Share		GAAP Measure			Stock Compensation Expense*			Intangible Asset Amortization*			Termination Costs & Other*			Equity-Method Investment Adjustments*			Income Tax Adjustments			Non- GAAP Measure
Net income		$	25,361			$	17,297			$	6,743			$	594			$	(414	)		$	(6,047	)		$	43,534
Diluted shares outstanding			33,265																								33,265
Diluted earnings per share		$	0.76																							$	1.31

* Represents pre-tax amounts

Unaudited Forward-Looking Statements Regarding Business Outlook

(In millions, except per share data)

		Three Months Ending April 1, 2023
Business Outlook		GAAP Measure			Non-GAAP Adjustments**			Non-GAAP Measure
Gross margin			63	%			0	%			63	%
Operating expenses		$	139			$	(28	)		$	111
Effective tax rate			31	%			(8	)%			23	%
Diluted earnings per share - low		$	0.36			$	0.71			$	1.07
Diluted earnings per share - high		$	0.46			$	0.71			$	1.17

** Non-GAAP adjustments include the following estimates: stock compensation expense of $16.6 million, intangible asset amortization of $6.5 million, termination costs of $5.4 million, and the associated tax impact from the aforementioned items.

Silicon Laboratories Inc.

Condensed Consolidated Balance Sheets

(In thousands, except per share data)

(Unaudited)

		December 31, 2022			January 1, 2022
Assets
Current assets:
Cash and cash equivalents		$	499,915			$	1,074,623
Short-term investments			692,024				964,582
Accounts receivable, net			71,437				98,313
Inventories			100,417				49,307
Prepaid expenses and other current assets			97,570				51,748
Total current assets			1,461,363				2,238,573
Property and equipment, net			152,016				146,516
Goodwill			376,389				376,389
Other intangible assets, net			84,907				118,978
Other assets, net			94,753				77,839
Total assets		$	2,169,428			$	2,958,295
Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable		$	89,860			$	47,327
Current portion of convertible debt, net			--				450,599
Deferred revenue and returns liability			6,780				13,849
Other current liabilities			89,136				157,052
Total current liabilities			185,776				668,827
Convertible debt, net			529,573				--
Other non-current liabilities			49,071				77,044
Total liabilities			764,420				745,871
Commitments and contingencies
Stockholders' equity:
Preferred stock - $0.0001 par value; 10,000 shares authorized; no shares issued			--				--
Common stock - $0.0001 par value; 250,000 shares authorized; 31,994 and 38,481 shares issued and outstanding at December 31, 2022 and January 1, 2022, respectively			3				4
Retained earnings			1,415,693				2,214,839
Accumulated other comprehensive loss			(10,688	)			(2,419	)
Total stockholders' equity			1,405,008				2,212,424
Total liabilities and stockholders' equity		$	2,169,428			$	2,958,295

Silicon Laboratories Inc.

Condensed Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

		Year Ended
		December 31, 2022			January 1, 2022
Operating Activities
Net income		$	91,402			$	2,117,399
Adjustments to reconcile net income to net cash provided by (used in) operating activities of continuing operations:
Income from discontinued operations, net of income taxes			--				(2,175,273	)
Depreciation of property and equipment			22,524				18,051
Amortization of other intangible assets			34,071				44,505
Amortization of debt discount and debt issuance costs			2,003				22,767
Loss on extinguishment of convertible debt			3				3,370
Stock-based compensation expense			60,510				56,842
Equity-method earnings			(3,400	)			(13,728	)
Deferred income taxes			(18,240	)			(3,414	)
Changes in operating assets and liabilities:
Accounts receivable			26,876				(3,144	)
Inventories			(51,044	)			(1,510	)
Prepaid expenses and other assets			(31,240	)			44,664
Accounts payable			36,797				(7,704	)
Other current liabilities and income taxes			(12,738	)			2,109
Deferred revenue and returns liability			(7,069	)			863
Other non-current liabilities			(9,181	)			(14,599	)
Net cash provided by operating activities of continuing operations			141,274				91,198
Investing Activities
Purchases of marketable securities			(607,237	)			(1,541,971	)
Sales of marketable securities			223,354				250,075
Maturities of marketable securities			650,946				844,966
Purchases of property and equipment			(26,525	)			(28,577	)
Purchases of other assets			--				(1,158	)
Net cash provided by (used in) investing activities of continuing operations			240,538				(476,665	)
Financing Activities
Payments on debt			(21	)			(140,572	)
Repurchases of common stock			(883,424	)			(1,150,044	)
Payment of taxes withheld for vested stock awards			(15,387	)			(22,239	)
Proceeds from the issuance of common stock			11,779				14,183
Net cash used in financing activities of continuing operations			(887,053	)			(1,298,672	)
Discontinued Operations
Operating activities			(69,467	)			(191,642	)
Investing activities			--				2,747,684
Net cash provided by (used in) discontinued operations			(69,467	)			2,556,042
Increase (decrease) in cash and cash equivalents			(574,708	)			871,903
Cash and cash equivalents at beginning of period			1,074,623				202,720
Cash and cash equivalents at end of period		$	499,915			$	1,074,623

Public link

Please use the above public link if you want to share this noodl on another website.